Really Tiny Stuff, Inc.

Really Tiny Stuff, Inc. is a private, biotechnology reasearch and development company, founded in 2002, that applies a diverse array of micro- and nano-technologies to engineer novel, innovative, breakthrough solutions to commercially significant problems. Current emphasis is on the development of a massively parallel DNA sequencing process, capable of achieving the "$1,000 Genome", to finally deliver the original promise of the Human Genome Project and open the door to truly personalized medicine.